Literature DB >> 2856918

Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.

G Wright, L Galloway, J Kim, M Dalton, L Miller, W Stern.   

Abstract

The effects of bupropion HCl in treating 11 patients with bipolar or schizoaffective disorder were examined in an open trial. Most patients had been intolerant of or showed minimal to moderate improvement on lithium, neuroleptics, antidepressants, or a combination of these drugs. All patients were maintained on bupropion alone or bupropion in combination with low-dose neuroleptics or anxiolytics for 1 year or more, with little or no relapse and few side effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856918

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Possible manic switch induced by combination of bupropion and electroconvulsive therapy in recurrent unipolar depression: a case series.

Authors:  Sahoo Saddichha; Ashish Soy; Pandey Vibha
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 3.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

4.  15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

Authors:  Maurizio Fava; A John Rush; Michael E Thase; Anita Clayton; Stephen M Stahl; James F Pradko; J Andrew Johnston
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 5.  Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines.

Authors:  Dian-Jeng Li; Ping-Tao Tseng; Yen-Wen Chen; Ching-Kuan Wu; Pao-Yen Lin
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.